Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Ledipasvir“
Suchtreffer
Begriffe & Kennungen
Harvoni · 4.8 · Ledipasvir/sofosbuvir was administered for 12 weeks to 18 patients with genotype 1 CHC and severe renal impair
Eintrag öffnenHarvoni · 4.8 · The safety profile of ledipasvir/sofosbuvir with ribavirin for 12 or 24 weeks in adults with decompensated liv
Eintrag öffnenHarvoni · 4.8 · The safety profile of ledipasvir/sofosbuvir with ribavirin for 12 or 24 weeks in adults with decompensated liv
Eintrag öffnenJuluca · 4.5 · 7 Cmin Cmax Sofosbuvir AUC Cmax 21% Sofosbuvir metabolite GS- 331007 AUC Cmax Ledipasvir/Sofos
Eintrag öffnenJuluca · 4.5 · Ledipasvir/Sofosbuvir Rilpivirine / Rilpivirine AUC 5% Cmin 7% Cmax 3% Ledipasvir AUC 2% Cmin 2%
Eintrag öffnenLokelma · 4.5 · 4 saquinavir, raltegravir, ledipasvir and rilpivirine) and tyrosine kinase inhibitors (erlotinib, dasatinib an
Eintrag öffnenPifeltro · 4.5 · ledipasvir ledipasvir + sofosbuvir AUC 0.92 (0.80, 1.06) (90 mg ledipasvir SD + Cmax 0.91 (0.80, 1.02) No dose
Eintrag öffnenRukobia · 4.5 · Sofosbuvir HCV-DAA Although not studied, temsavir may Ledipasvir increase plasma concentrations of Velpatasv
Eintrag öffnenSovaldi · 4.8 · Patients with Renal Impairment Sofosbuvir in a fixed dose combination with ledipasvir was administered for 12
Eintrag öffnenSovaldi · 4.8 · Patients with Renal Impairment Sofosbuvir in a fixed dose combination with ledipasvir was administered for 12
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 40% Cmax: ↔ Cmin: ↑ 91% Ledipasvir/Sofosbuvir Sofosbuvir: No dose adjustment is (90 mg/400 m
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 50% Cmax: ↑ 64% Cmin: ↑ 59% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/4
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↑ 98% Cmax: ↑ 79% Cmin: ↑ 163% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 25% Cmin: ↔ 1 Data generated from simultaneous dosing with ledipasvir/sofosbuvir. St
Eintrag öffnenTenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 47% Cmin: ↑ 47% Ledipasvir/Sofosbuvir Ledipasvir: Increased plasma (90 mg/400 mg q.d
Eintrag öffnenTenofovir disoproxil Zentiva · 4.5 · Tenofovir: AUC: ↔ Cmax: ↑ 25% Cmin: ↔ 1 Data generated from simultaneous dosing with ledipasvir/sofosbuvir. St
Eintrag öffnenTruvada · 4.5 · Ledipasvir: AUC: ↔ Cmax: ↔ Cmin: ↔
Eintrag öffnenTruvada · 4.5 · Tenofovir: AUC: ↑ 98% (↑ 77 to ↑ 123) Cmax: ↑ 79% (↑ 56 to ↑ 104) Cmin: ↑ 163% (↑ 137 to ↑ 197) Ledipasvir/Sof
Eintrag öffnenViread · 4.5 · Tenofovir: AUC: ↑ 98% Cmax: ↑ 79% Cmin: ↑ 163% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/
Eintrag öffnenViread · 4.5 · Tenofovir: AUC: ↑ 98% Cmax: ↑ 79% Cmin: ↑ 163% Ledipasvir/Sofosbuvir Ledipasvir: No dose adjustment is (90 mg/
Eintrag öffnen